These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 884928)

  • 21. The origins and kinetics of bilirubin in dogs with hepatobiliary and haemolytic diseases.
    Rothuizen J; van den Brom WE; Fevery J
    J Hepatol; 1992 May; 15(1-2):17-24. PubMed ID: 1506635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sources of bile pigment overproduction in Gilbert's syndrome: studies with non-radioactive bilirubin kinetics and with delta-[3,5-3H]aminolaevulinic acid and [2-14C]glycine.
    Zeneroli ML; Piaggi V; Cremonini C; Gozzi C; Ventura E
    Clin Sci (Lond); 1982 Jun; 62(6):643-9. PubMed ID: 7083755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of acute infectious hepatitis and cirrhosis of the liver on the nonerythropoietic component of early bilirubin.
    Tarao K; Fukushima K; Endo O; Kamiyo A
    J Lab Clin Med; 1976 Feb; 87(2):240-50. PubMed ID: 1245790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic clearance of unconjugated bilirubin in cholestatic liver diseases.
    Bloomer JR; Berk PD; Howe RB
    Am J Dig Dis; 1974 Jan; 19(1):9-14. PubMed ID: 4809035
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of sodium phenobarbital on bilirubin metabolism in an infant with congenital, nonhemolytic, unconjugated hyperbilirubinemia, and kernicterus.
    Crigler JF; Gold NI
    J Clin Invest; 1969 Jan; 48(1):42-55. PubMed ID: 5765026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physico-chemical factors predisposing to pigment gallstone formation in liver cirrhosis.
    Alvaro D; Angelico M; Gandin C; Ginanni Corradini S; Capocaccia L
    J Hepatol; 1990 Mar; 10(2):228-34. PubMed ID: 2332595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative studies of the delivery of hepatic-synthesized bilirubin to plasma utilizing -aminolevulinic acid-4- 14 C and bilirubin- 3 H in man.
    Jones EA; Shrager R; Bloomer JR; Berk PD; Howe RB; Berlin NI
    J Clin Invest; 1972 Sep; 51(9):2450-8. PubMed ID: 4639027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective methionine metabolism in cirrhosis: relation to severity of liver disease.
    Marchesini G; Bugianesi E; Bianchi G; Fabbri A; Marchi E; Zoli M; Pisi E
    Hepatology; 1992 Jul; 16(1):149-55. PubMed ID: 1377658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of fibrinogen in cirrhosis of the liver.
    Tytgat GN; Collen D; Verstraete M
    J Clin Invest; 1971 Aug; 50(8):1690-701. PubMed ID: 5163179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT; Marigold JH; Thompson RP
    Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis.
    Nomura S; Pittman CS; Chambers JB; Buck MW; Shimizu T
    J Clin Invest; 1975 Sep; 56(3):643-52. PubMed ID: 1159078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenobarbital does not increase early labeling of bilirubin from 4-[14C]-delta-aminolevulinic acid in man and rat.
    Okuda H; Tavoloni N; Blaschke TF; Kiang CL; Jones MJ; Waggoner JG; Sardana MK; Sassa S; Shrager RI; Berk PD
    Hepatology; 1991 Dec; 14(6):1153-60. PubMed ID: 1959865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of bilirubin kinetics with respect to the diagnosis of Gilbert's syndrome.
    Okolicsanyi L; Ghidini O; Orlando R; Cortelazzo S; Benedetti G; Naccarato R; Manitto P
    Clin Sci Mol Med; 1978 May; 54(5):539-47. PubMed ID: 750155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in lipids, bilirubin and metal elements in the gallbladder bile in patients with cirrhosis of the liver].
    Zhu JF; Shan LC; Chen WH
    Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):767-9. PubMed ID: 7600868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis.
    Potter BJ; Elias E; Jones EA
    J Lab Clin Med; 1976 Sep; 88(3):427-39. PubMed ID: 956695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unconjugated and conjugated bilirubin pigments during perinatal development. I. Studies on rat serum and intestine.
    Muraca M; Blanckaert N; Rubaltelli FF; Fevery J
    Biol Neonate; 1986; 49(2):90-5. PubMed ID: 3697432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The extent of reflux of unconjugated 14C-cholic acid from the liver in subjects with normal liver function.
    Collins DM; Bates JH; Maslowski AH; McKinnon AE; Campbell CB
    Aust J Exp Biol Med Sci; 1981 Dec; 59(Pt 6):779-90. PubMed ID: 7340775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow.
    Nosadini R; Avogaro A; Mollo F; Marescotti C; Tiengo A; Duner E; Merkel C; Gatta A; Zuin R; de Kreutzenberg S
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1125-32. PubMed ID: 6373811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bilirubin and bile acid metabolism in cirrhotic rats].
    Huang Y
    Zhonghua Yi Xue Za Zhi; 1990 Oct; 70(10):567-9, 40. PubMed ID: 2176567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis.
    Orlando R; Sawadogo A; Miglioli PA; Cappellazzo MG; Palatini P
    Chemotherapy; 1992; 38(1):1-6. PubMed ID: 1617997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.